PIPE-791
CTX-791-102
Phase 1 small_molecule completed
Quick answer
PIPE-791 for Idiopathic Pulmonary Fibrosis (IPF) is a Phase 1 program (small_molecule) at Contineum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Contineum Therapeutics
- Indication
- Idiopathic Pulmonary Fibrosis (IPF)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed